Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Oragenics Inc (OGEN)

Oragenics Inc (OGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,827
  • Shares Outstanding, K 61,005
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,570 K
  • 60-Month Beta 0.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 18.93
Trade OGEN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.43
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5175 +4.54%
on 10/22/20
0.7792 -30.57%
on 10/06/20
-0.1506 (-21.78%)
since 09/22/20
3-Month
0.5175 +4.54%
on 10/22/20
1.4900 -63.69%
on 07/23/20
-0.9490 (-63.69%)
since 07/22/20
52-Week
0.3600 +50.28%
on 04/16/20
2.0900 -74.11%
on 07/22/20
+0.0850 (+18.64%)
since 10/22/19

Most Recent Stories

More News
Recent Events Reinforce the Importance of Surface Sterilization

, /PRNewswire/ -- The pandemic continues to take a toll on the world's economy, and as a result, effective and cheap mass testing is needed to properly implement preventive measures. Since the pandemic...

ABT : 109.48 (+3.35%)
VYST : 0.0601 (-5.80%)
RLFTF : 0.5566 (+0.02%)
IBIO : 1.9800 (+4.76%)
OGEN : 0.5410 (+0.54%)
PCTL : 0.0258 (+1.18%)
Thinking about buying stock in Jaguar Health, Oragenics, Plug Power, FuelCell Energy, or Norwegian Cruise Line?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, OGEN, PLUG, FCEL, and NCLH.

NCLH : 17.71 (+4.24%)
OGEN : 0.5410 (+0.54%)
FDA Broadly Supports Oragenics' Pre-IND Development Program for its SARS-CoV-2 Vaccine

Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company") announced receipt of feedback to its Type B Pre-IND Meeting Request from the U.S. Food and Drug Administration ("FDA") that it is in...

OGEN : 0.5410 (+0.54%)
Oragenics Provides an Update on Funding for its SARS-CoV-2 Vaccine

Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company") provides an update on U.S. federal government and other funding options the Company is pursuing in order to advance its SARS-CoV-2 vaccine,...

OGEN : 0.5410 (+0.54%)
Companies Rush to Develop Innovative Disinfecting Technologies

, /PRNewswire/ -- The pandemic has drastically reshaped the global social and economic landscape. Countries have shut down schools and businesses, restricted travel, postponed entertainment and sporting...

OPTI : 0.0268 (-4.29%)
VYST : 0.0601 (-5.80%)
TPTW : 0.0359 (-13.70%)
OGEN : 0.5410 (+0.54%)
IBIO : 1.9800 (+4.76%)
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference

Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company dedicated to the development and commercialization of a vaccine candidate to combat the novel coronavirus pandemic (commonly referred...

OGEN : 0.5410 (+0.54%)
Thinking about buying stock in Oragenics Inc, Fortress Biotech, Super League Gaming, CleanSpark Inc, or iBio Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OGEN, FBIO, SLGG, CLSK, and IBIO.

FBIO : 2.68 (+4.28%)
IBIO : 1.9800 (+4.76%)
OGEN : 0.5410 (+0.54%)
Thinking about buying stock in General Electric, Gevo Inc, Micron Technology, Oragenics Inc, or Alibaba?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GE, GEVO, MU, OGEN, and BABA.

BABA : 306.28 (-0.55%)
GE : 7.72 (+5.46%)
MU : 54.38 (+2.01%)
OGEN : 0.5410 (+0.54%)
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine

Oragenics, Inc. (NYSE American: OGEN) and Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today announced that the companies have entered into a process development and drug substance manufacturing...

OGEN : 0.5410 (+0.54%)
CDMO : 8.15 (+2.13%)
CDMOP : 26.52 (-0.67%)
Oragenics, Inc. to Present at the June 2020 Virtual Summer Investor Summit

Oragenics, Inc. (NYSE American: OGEN), announced today that Alan Joslyn, Ph.D., President and CEO of Oragenics, Inc., will give a virtual corporate presentation at the June 2020 Virtual Summer Investor...

OGEN : 0.5410 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Oragenics Inc is a biotechnology company focused on the development and licensure of innovative products and technologies for improving human health.

See More

Key Turning Points

2nd Resistance Point 0.5687
1st Resistance Point 0.5548
Last Price 0.5410
1st Support Level 0.5223
2nd Support Level 0.5037

See More

52-Week High 2.0900
Fibonacci 61.8% 1.4291
Fibonacci 50% 1.2250
Fibonacci 38.2% 1.0209
Last Price 0.5410
52-Week Low 0.3600

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar